Align Technology, Inc.

ALGN Healthcare Medical Instruments & Supplies

Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.

Revenue
+1.92%
EPS
+143.9%
Free cash flow
+8.26%

Quarter to September 2026, against a year earlier

158.87 6.03 −3.66%
Market cap
$11.3B
P/E
23.1×
Fwd P/E
20.4×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.52
Dividend safety
n/a
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
21.12 29.28 28.72 27.59

+8 more quarters

P/S ratio
2.48 2.91 2.99 2.81
P/FCF ratio
15.41 17.85 20.98 23.08
P/Operating CF
56.41 62.56 81.07 50.76
P/B ratio
2.44 2.85 2.95 2.80
EV/Sales
2.21 2.65 2.73 2.54
EV/EBITDA
11.44 13.66 13.78 13.07
EV/FCF
13.70 16.22 19.16 20.85
Current Ratio
1.42 1.40 1.39 1.36
Net Debt/EBITDA
0.00 (5.68) (5.34) (4.26)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
4.73% 3.42% 3.48% 3.62%
Free Cash Flow Yield
6.49% 5.60% 4.77% 4.33%
Free Cash Flow per Share
2.58 2.78 1.68 2.58
Book value per Share
60.65 59.20 58.09 55.82
Free Cash Flow
182.92 199.09 120.26 187.26
EV/EBIT
14.79 20.01 20.09 18.75
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026